Perspectives: Posttransplantation bone disease

Journal of Bone and Mineral Research

Volumn 7, Issue 2, 1992, Pages 123-126

  Katz, Ian A ^a   Epstein, Sol ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; CYCLOSPORIN;

BONE TRANSPLANTATION; GRAFT REJECTION; HUMAN; NOTE; BONE DISEASE; ORGAN TRANSPLANTATION; REVIEW;

BONE DISEASES; CYCLOSPORINE; HUMAN; ORGAN TRANSPLANTATION;

EID: 0026527463     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.5650070202     Document Type: Article

References (33)

1. Glucocorticoid‐induced osteoporosis
2. Drug‐induced osteoporosis
3. Bone disease in patients with primary biliary cirrhosis
4. Bone disease in liver transplant recipients: Incidence, timing, and risk factors
5. Does iron affect osteoblast function? Studies in vitro and in patients with chronic liver disease
6. Metabolic bone disease of total parenteral nutrition: Course after changing from casein to amino acids in parenteral solutions with reduced aluminum content
7. Loss of vertebral bone density in heart transplant patients
8. Cyclosporin A associated osteoporosis in cardiac transplant patients
9. Osteopenia in cardiac transplant recipients
10. Reduced bone mineral density in men and women with allogeneic bone marrow transplantation
11. Rapid loss of vertebral mineral density after renal transplantation
12. Steroid‐induced fractures and bone loss in patients with asthma
13. Glucocorticoid‐induced osteoporosis: Pathogenesis and management
14. Persistent elevation of alkaline phosphatase in cyclosporine‐treated renal transplant recipients
15. Cyclosporine A inhibits calcemic hormone‐induced bone resorption in vitro
16. Cyclosporines: Correlation of immunosuppressive activity and inhibition of bone resorption
17. Cyclosporin A in vitro decreases bone resorption, osteoclast formation and fusion of cells of the monocyte‐macrophage lineage
18. Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone
19. Cyclosporine‐A in vivo produces severe osteopenia in the rat: Effect of dose and duration of administration
20. Circulating osteocalcin in primary biliary cirrhosis following liver transplantation and during treatemnt with cyclosporin
21. Comparison of the effects of cyclosporin A and Fk 506 on bone mineral metabolism in the rat
22. Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone
23. Potential protection by cyclosporin against glucocorticoid effects on bone
24. The present and future of kidney transplantation
25. Cardiac transplantation: Current indications and limitations
26. Sequential discontinuation of azathioprine and prednisone in renal transplantation
27. Adult height achieved in children after kidney transplantation
28. Cyclosporin A and osteonecrosis of the femoral head
29. Avascular necrosis of bone marrow transplant patients
30. Salmon calcitonin prevents cyclosporin‐A‐induced high turnover bone loss
31. The bisphosphonate 2‐PEBP inhibits cyclosporin A induced high turnover osteopenia in the rat
32. Is there an effective treatment for glucocorticoid‐induced osteoporosis?